WellPoint Will Put Comparative Effectiveness Guidance In Updated Drug Assessment Criteria
This article was originally published in The Pink Sheet Daily
Executive Summary
The health insurer's next iteration of its technology assessment criteria, used for evaluating drugs for formulary inclusion, will likely be published by the end of the year.